Hadj Benzerdjeb

Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

Paul O’Connor, Jerry S. Wolinsky, Christian Confavreux et al. · New England Journal of Medicine · 2011 · 976 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years

Christian Confavreux, David K. Li, Mark S. Freedman et al. · Multiple Sclerosis Journal · 2012 · 141 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +16

Teriflunomide added to interferon-β in relapsing multiple sclerosis

M. S. Freedman, Jerry S. Wolinsky, Barbara D. Wamil et al. · Neurology · 2012 · 78 citations

Pharmacy, Neurology, Pharmacotherapy +17

Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine

Rohit Singhal, Alison H. Harrill, Françoise Menguy-Vacheron et al. · BMC Pharmacology and Toxicology · 2014 · 56 citations · Full text

Medicine, Internal Medicine, Pharmacology +17

Pregnancy Outcomes from the Teriflunomide Clinical Development Program: Retrospective Analysis of the Teriflunomide Clinical Trial Database (S30.005)

Lily Jung Henson, Olaf Stüve, Bernd C. Kieseier et al. · Neurology · 2013 · 11 citations

Medicine, Pharmacology, Pharmacotherapy +16